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Abstract
Background: MedicineInsight is a database containing de-identified electronic health records (EHRs) from over 700
Australian general practices. It is one of the largest and most widely used primary health care EHR databases in
Australia. This study examined the validity of algorithms that use information from various fields in the
MedicineInsight data to indicate whether patients have specific health conditions. This study examined the validity
of MedicineInsight algorithms for five common chronic conditions: anxiety, asthma, depression, osteoporosis and
type 2 diabetes.
Methods: Patients’ disease status according to MedicineInsight algorithms was benchmarked against the recording
of diagnoses in the original EHRs. Fifty general practices contributing data to MedicineInsight met the eligibility
criteria regarding patient load and location. Five were randomly selected and four agreed to participate. Within
each practice, 250 patients aged ≥ 40 years were randomly selected from the MedicineInsight database. Trained
staff reviewed the original EHR for as many of the selected patients as possible within the time available for data
collection in each practice.
Results: A total of 475 patients were included in the analysis. All the evaluated MedicineInsight algorithms had
excellent specificity, positive predictive value, and negative predictive value (above 0.9) when benchmarked against
the recording of diagnoses in the original EHR. The asthma and osteoporosis algorithms also had excellent
sensitivity, while the algorithms for anxiety, depression and type 2 diabetes yielded sensitivities of 0.85, 0.89 and
0.89 respectively.
Conclusions: The MedicineInsight algorithms for asthma and osteoporosis have excellent accuracy and the
algorithms for anxiety, depression and type 2 diabetes have good accuracy. This study provides support for the use
of these algorithms when using MedicineInsight data for primary health care quality improvement activities,
research and health system policymaking and planning.
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Background
Electronic health records (EHRs) are used in primary
health care settings to keep patient-level records of
clinical information including diagnoses, reasons for
encounters, prescriptions, observations, test results
and referrals [1]. The development of tools to extract
the data contained in these EHRs has allowed for the
establishment of primary health care EHR databases
which have proven to be a valuable resource for
health research and public health surveillance. Widely
used examples from across the world include the
Clinical Practice Research Datalink (CPRD) [2] and
The Health Improvement Network (THIN) database
[3] in the United Kingdom (UK), and the Canadian
Primary Care Sentinel Surveillance Network (CPCS
SN) [4]. Primary health care EHR data have been
used to improve our understanding of the epidemi-
ology of diseases and the use, costs and outcomes of
health care practices, as well as for disease surveil-
lance and quality improvement in primary health care
[2, 5, 6].
In Australia, the majority of general practitioners use
EHRs to manage their patient care, including writing
prescriptions, ordering pathology tests and filing corres-
pondence. A variety of EHR clinical information systems
are in use, all with different data structures and termin-
ologies. This lack of interoperability means that EHR
data is not routinely shared between practices, although
efforts to change this are underway with the introduc-
tion of the national cloud-based My Health Record [7].
There has been limited use of Australian primary health
care EHR data for research and surveillance, because of
data access barriers [1, 8]. These obstacles have been
overcome by the establishment of centralised repositor-
ies, which are now facilitating timely access to EHR data
from Australian general practices [8]. MedicineInsight,
which has national coverage, is one of the largest and
most widely used of these Australian databases. Details
of this resource are described elsewhere [9]. Briefly,
MedicineInsight was established in 2011 and contains
de-identified EHRs from just over 700 of Australia’s
8147 general practices [10]. MedicineInsight focuses on
practices using Best Practice [BP]™ or Medical Director
[MD]™, the most widely used clinical information sys-
tems in Australia (over 80 % coverage) and the most
similar in structure, noting that they were designed by
the same individual [7]. A whole-of-practice data collec-
tion, containing all available EHRs in the practice’s clin-
ical information system is conducted when a practice
joins MedicineInsight. Extracted data include patient
demographics and clinical data entered directly into
fields within the EHR by healthcare professionals. Free
text fields potentially containing identifying information,
such as progress notes and correspondence, are not
included in the extraction. Incremental data are ex-
tracted regularly, resulting in an updated longitudinal
database in which patients within each practice can be
tracked over time. Data from practices using BP and
MD software are merged into a single consistent data
structure, and monthly builds of the database are gener-
ated and made available for use.
As is the case for many of these primary health care
EHR databases, MedicineInsight contains diagnostic al-
gorithms [1] that use information from various EHR
fields to identify whether patients have specific health
conditions. Such algorithms are required because there
is no single field that provides definitive information on
the health conditions experienced by each patient. The
MedicineInsight algorithms have been developed by NPS
MedicineWise, the custodian of MedicineInsight, to cre-
ate efficiencies for users of the data and promote
consistency between studies.
Knowledge of the extent to which these algorithms
accurately identify patients’ disease status is key to
understanding the potential biases that may arise in
analyses using these algorithms. This is essential for
the appropriate interpretation of results of analyses of
MedicineInsight data. Indeed, validation studies of al-
gorithms used to identify patients with health condi-
tions in routinely collected data have been recognized
as a priority for health services research [11, 12]. Al-
though the MedicineInsight algorithms for many con-
ditions have been demonstrated to yield prevalence
estimates that are similar to those produced by other
reputable data sources [13–15], there has been no
formal assessment of their validity. The findings from
the numerous validation studies of diagnostic
algorithms in primary health care EHR data in other
developed countries [16] cannot be assumed to gener-
alise to Australian data, due to between-country dif-
ferences in the operation and funding of the health
care system and differences in the variables available
in different databases [12].
The purpose of this study was to examine the validity
of MedicineInsight algorithms for five common chronic
conditions in general practice: anxiety, asthma, depres-
sion, osteoporosis and type 2 diabetes.
Methods
We compared each patient’s disease status according to
the diagnostic algorithms in the MedicineInsight data-
base to their status determined through review of the
original EHRs held in the participating practices.
Study population
This study was based on patients attending four general
practices participating in MedicineInsight. To be eligible,
practices had to meet the following criteria:
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i) data related to activity in October 2019 were
successfully extracted;
ii) at least 250 patients aged 40 years and older with
an encounter in October 2019;
iii) located within 40 km of the Sydney or Melbourne
central business districts, to ensure ease of access
for EHR reviewers (Sydney and Melbourne are the
capital cities of Australia’s two most populous
states); and.
iv) participated in at least one MedicineInsight quality
improvement activity in the period November 2018
to October 2019, to ensure interest in engaging
with the MedicineInsight program.
We categorised the 50 practices meeting these criteria
according to the EHR software used (BP or MD) and the
city in which the practice is located (Sydney or Mel-
bourne). We randomly selected one practice from each
of these four categories (BP Sydney, MD Sydney, BP
Melbourne and MD Melbourne); additional practices
were selected until one from each category agreed to
participate. We stratified our random selection by the
EHR software used so that we could examine whether
the software contributed to any differences in the valid-
ity of the MedicineInsight algorithms. We stratified by
city to evenly distribute the data collection between EHR
reviewers based in the two cities. Five practices were is-
sued with invitations to participate before four con-
firmed participation by providing written informed
consent.
Using MedicineInsight data, we selected patients who
were aged 40 years and older and attended the partici-
pating practices in October 2019. This age restriction in-
creased the prevalence of the evaluated conditions,
thereby optimising statistical power. We randomly se-
lected 250 of these patients per practice. We aimed to
collect data for as many of these patients as possible
within the five days of data collection planned at each
practice.
MedicineInsight diagnostic algorithms
MedicineInsight personnel have developed coding algo-
rithms that identify patients with specific health condi-
tions. These algorithms identify conditions using
information from three EHR fields: diagnosis, reason for
visit and reason for prescription. These fields either con-
tain coded terms that the user selects from a drop-down
list in the EHR software, or free text. ‘Pyefinch’ coding is
available in BP, while ‘Docle’ coding is available in MD.
The algorithms identify patients as having the specific
health condition if a coded term or text string from the
pre-defined list has ever been recorded for that patient
in any one of the three fields. The pre-defined list of
coded terms and text strings is compiled by trained
clinical coders, and is based on available Pyefinch and
Docle codes, as well as commonly accepted clinical defi-
nitions and abbreviations. For records identified by a
free text string alone, the context in which it is recorded
is reviewed by clinical coders at the time of developing
the algorithm and periodically thereafter, and irrelevant
instances removed. A detailed description of the
MedicineInsight algorithms for anxiety, asthma, depres-
sion, osteoporosis and type 2 diabetes is included in
Additional File 1.
For the purposes of this study, the diagnostic algo-
rithms were applied to MedicineInsight data up to 31
October 2019. To ensure that the results of EHR reviews
could not influence the classification of patients on the
diagnostic algorithms, values on the diagnostic algo-
rithms were extracted from the MedicineInsight data-
base prior to the conduct of EHR reviews. These data
extracts were provided to an analyst who did not have
access to any additional MedicineInsight data.
EHR reviews
Information obtained from the original EHRs held in the
participating practices was used as the reference stand-
ard against which accuracy was benchmarked. Three
EHR reviewers visited the participating practices be-
tween January and March 2020 and accessed the original
EHRs for the randomly selected patients. All EHR re-
viewers were health professionals registered with the
Australian Health Practitioner Regulation Agency, and
thus accredited for the keeping of medical records and
adherence to confidentiality and privacy principles.
Anonymised identifiers for these patients (extracted
from the MedicineInsight data) were reassociated with
patient names using the third-party data extraction tools
installed on computers at each practice. EHR reviewers
completed reviews for as many of the 250 selected pa-
tients as possible within the time available in the prac-
tice, which ranged from three to eight days. To minimise
the inconvenience to practices, we planned only five
days of data collection in each practice. In one practice,
EHR reviews were particularly time consuming due to
the size of the records, so an extra three days of data
collection were completed. In two of the practices, it was
necessary to close data collection early due to COVID-
19, with three days of data collection completed in one,
and four days in the other. EHR reviewers worked
through the randomly ordered list of selected patients
from the beginning, without skipping any.
Guided by a standardised electronic data capture form,
the EHR reviewers searched for evidence of the specific
health conditions in the following fields: diagnosis, rea-
son for visit, reason for prescription, correspondence and
progress notes. If a diagnosis of the condition (recording
of symptoms was not sufficient) was recorded in any of
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these fields, or if it was documented that the patient was
undergoing treatment that is highly specific to the spe-
cific condition (e.g. asthma care plan), the patient was
considered to have the condition. The term ‘anxiety’ was
the exception; it can be used to represent symptoms, but
it is often used to indicate anxiety disorder. If it was not
clear from the context whether the term ‘anxiety’ was
meant to represent symptoms or a diagnosis, it was as-
sumed to be a diagnosis. For osteoporosis, the investiga-
tions/results fields were also searched for a diagnosis
recorded on bone mineral density test results. The inves-
tigations/results fields were also searched for type 2 dia-
betes. If a diagnosis was recorded or results of fasting
blood glucose tests, oral glucose tolerance tests or gly-
cated haemoglobin tests were consistent with the Royal
Australian College of General Practitioners’ diagnostic
criteria for type 2 diabetes [17], the patient was consid-
ered to have type 2 diabetes. EHR reviewers were
blinded to the patient’s disease status on the Medici-
neInsight algorithms. EHR reviewers were instructed to
ignore any evidence documented after 31 October 2019,
as the algorithms were applied to MedicineInsight data
up to this date. The EHR data were collected and man-
aged using REDCap electronic data capture tools hosted
at The University of Melbourne.
Analysis
For each health condition, the sensitivity, specificity, posi-
tive predictive value (PPV) and negative predictive value
(NPV) of the MedicineInsight algorithms were calculated.
These measures of accuracy are defined in Table 1. As the
data are clustered within practices, variance was adjusted
to account for correlation between observations within
clusters, and confidence intervals adjusted accordingly.
Analyses were conducted using R, version 3.6.2 [18].
Results
Within the time available for data collection, EHR re-
views were conducted for 477 patient records. One of
these EHR reviews was not included in the analyses be-
cause the EHR indicated that it was a test record (as op-
posed to belonging to a real patient), while another was
excluded because the EHR review record could not be
linked to a patient record in the MedicineInsight data
extract due to a data entry error in the study patient
identifier. This resulted in the inclusion of 475 patients
in the analysis, distributed across practices as follows: BP
Sydney, 3 days, n = 65 (14 %); MD Sydney, 5 days, n =
194 (41 %); BP Melbourne, 8 days, n = 110 (23 %); and
MD Melbourne, 4 days, n = 106 (22 %). 40 % of the final
sample were male; 61 % were aged 40 to 64 years, with
the remainder 65 years or older; and 37 % had EHRs
based on BP software, with the remainder in MD
software.
Concordance between the MedicineInsight diagnostic
algorithms and EHR reviews is presented in Table 2.
Based on EHR reviews for these 475 patients aged ≥ 40
years, 163 (34 %) patients had anxiety. The diagnostic al-
gorithm for identifying patients with anxiety yielded ex-
cellent specificity, PPV and NPV (all 0.93 and above)
and a sensitivity of 0.85. According to EHR reviews,
23 % of patients had a diagnosis of asthma recorded ever,
and 11 % had osteoporosis. The diagnostic algorithms
for asthma and osteoporosis both yielded excellent sensi-
tivity, specificity, PPV and NPV (all 0.94 and above).
35 % of patients ever had a diagnosis of depression re-
corded, and 15 % had type 2 diabetes. The diagnostic al-
gorithms for depression and type 2 diabetes yielded
excellent specificity, PPV and NPV (all 0.94 and above),
and both yielded a sensitivity of 0.89.
When the calculation of these measures of accuracy
was stratified according to the EHR software used (BP or
MD), non-overlapping confidence intervals indicated
statistically significant differences in the NPV for asthma
(0.93, 95 % CI: 0.90–0.95 in BP and 1.00, 95 % CI: 0.99–
1.00 in MD), the PPV for osteoporosis (1.00, 95 % CI:
0.98–1.00 in BP and 0.92, 95 % CI: 0.80–0.97 in MD),
and the specificity for type 2 diabetes (0.99, 95 % CI:
0.98–0.99 in BP and 1.00, 95 % CI: 1.00–1.00 in MD).
While statistically significant, these differences have no
obvious clinical significance (see Table 3).
Discussion
This study found that all five MedicineInsight diagnostic
algorithms evaluated had excellent specificity, PPV and
NPV. The high specificities and PPVs indicate that these
algorithms return few false positives and are therefore
useful for identifying cohorts of patients who truly have
the specific condition and for classifying outcomes [19].
The asthma and osteoporosis algorithms also had excel-
lent sensitivity, making them valuable for identifying
representative cohorts of patients and for measuring the
prevalence of these conditions. The algorithms for
Table 1 Definitions of measures of accuracy
Sensitivity: the number of patients that are identified by the
MedicineInsight algorithm as having the specific health condition,
as a proportion of patients who truly have the specific health
condition (according to EHR reviews)
Specificity: the number of patients that are identified by the
MedicineInsight algorithm as not having the specific health condition,
as a proportion of patients who truly do not have the specific health
condition
Positive predictive value (PPV): the number of patients that truly have
the specific health condition, as a proportion of patients identified by
the MedicineInsight algorithm as having the specific health condition.
Negative predictive value (NPV): the number of patients that truly do
not have the specific health condition, as a proportion of patients
identified by the MedicineInsight algorithm as not having the specific
health condition.
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anxiety, depression and type 2 diabetes yielded sensitiv-
ities below 0.9, which indicates that some patients who
have these conditions are incorrectly classified as not
having these conditions. As a result, use of these algo-
rithms will lead to undercounting of patients with these
conditions and this should be borne in mind when inter-
preting the findings of analyses involving these algo-
rithms. Nevertheless, this level of under ascertainment is
generally considered acceptable, with many prior valid-
ation studies of primary health care EHR data interpret-
ing sensitivities of this magnitude as evidence of good
accuracy [4, 16, 20].
Three of the evaluated MedicineInsight diagnostic al-
gorithms have accuracy that is comparable to, or super-
ior to, the accuracy of diagnostic algorithms in
electronic primary health care databases in other parts
of the world. According to a recent systematic review,
other asthma algorithms have yielded sensitivities ran-
ging from 0.74 to 0.92, specificities ranging from 0.84 to
0.98, PPVs ranging from 0.67 to 0.81 and NPVs of 0.9
and above [16]. Depression algorithms have returned
sensitivities ranging from 0.73 to 0.81, PPVs ranging
from 0.79 to 0.87 and specificities and NPVs of 0.9 and
above [16]. Type 2 diabetes algorithms have yielded sen-
sitivities ranging from 0.65 to 1.0, PPVs ranging from
0.87 to 1.0 and specificities and NPVs of 0.94 and above
[16]. To our knowledge, there have been no prior valid-
ation studies of anxiety or osteoporosis algorithms in
primary health care data.
Strengths and limitations
A strength of this study is that EHR reviews were con-
ducted for patients that the algorithm identified as cases
as well as those the algorithm considered non-cases. In-
cluding both cases and non-cases in a study allows for
the calculation of sensitivity, specificity, NPV and PPV,
where all of these measures are important because each
describes a different aspect of accuracy and allows the
reader to consider how the algorithm will perform in a
particular context [19]. Despite this, many studies have
not collected reference standard data for non-cases, in-
stead opting to seek confirmation only for patients

























Anxiety 139 7 24 305 0.85 (0.77–0.91) 0.98 (0.96–0.99) 0.95 (0.90–0.98) 0.93 (0.87–0.96)
Asthma 98 1 10 366 0.91 (0.79–0.96) 1.00 (0.98–1.00) 0.99 (0.93–1.00) 0.97 (0.92–0.99)
Depression 149 7 19 300 0.89 (0.86–0.91) 0.98 (0.96–0.99) 0.96 (0.92–0.98) 0.94 (0.92–0.96)
Osteoporosis 48 2 3 422 0.94 (0.86–0.98) 1.00 (0.98–1.00) 0.96 (0.83–0.99) 0.99 (0.99–1.00)
Type 2
diabetes
63 2 8 402 0.89 (0.83–0.93) 1.00 (0.98–1.00) 0.97 (0.92–0.99) 0.98 (0.97–0.99)




























Anxiety 49 1 13 112 0.79 (0.77–0.81) 0.99 (0.97–1.00) 0.98 (0.95–0.99) 0.90 (0.87–0.92)
Asthma 47 1 9 118 0.84 (0.67–0.93) 0.99 (0.96–1.00) 0.98 (0.84–1.00) 0.93 (0.90–0.95)
Depression 55 1 6 113 0.90 (0.85–0.94) 0.99 (0.95–1.00) 0.98 (0.90–1.00) 0.95 (0.91–0.97)
Osteoporosis 25 0 1 149 0.96 (0.89–0.99) 1.00 (1.00–1.00) 1.00 (0.98–1.00) 0.99 (0.98–1.00)
Type 2
diabetes
37 2 3 133 0.92 (0.84–0.97) 0.99 (0.98–0.99) 0.95 (0.91–0.97) 0.98 (0.94–0.99)
Medical
Director
Anxiety 90 6 11 193 0.89 (0.81–0.94) 0.97 (0.95–0.98) 0.94 (0.89–0.97) 0.95 (0.88–0.98)
Asthma 51 0 1 248 0.98 (0.93–1.00) 1.00 (1.00–1.00) 1.00 (0.93–1.00) 1.00 (0.99–1.00)
Depression 94 6 13 187 0.88 (0.85–0.91) 0.97 (0.95–0.98) 0.94 (0.91–0.96) 0.94 (0.91–0.95)
Osteoporosis 23 2 2 273 0.92 (0.80–0.97) 0.99 (0.98–1.00) 0.92 (0.80–0.97) 0.99 (0.98–1.00)
Type 2
diabetes
26 0 5 269 0.84 (0.66–0.95) 1.00 (1.00–1.00) 1.00 (0.87–1.00) 0.98 (0.97–0.99)
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identified as cases by the algorithm. While this reduces
the total number of patients for whom reference stand-
ard data needs to be collected, such an approach means
that PPV is the only measure of accuracy that can be
calculated. To attain sufficient statistical power in the
current study, the sample was restricted to patients aged
40 years and older. This represents a trade-off in terms
of generalisability of the PPV and NPV estimates. As es-
timates of PPV and NPV depend on the prevalence of
the specific health condition [11], the PPV estimates
returned in this study may be higher, and our NPV esti-
mates may be lower, than those yielded by the diagnostic
algorithms in a population with a lower prevalence of
the condition. The prevalence of the five conditions in
our sample was approximately twice that of the whole
MedicineInsight patient sample [14]. In addition to the
age restriction, this increased prevalence is likely due to
the focus on patients with a recent visit to a general
practitioner, the chance of which would be higher in fre-
quent attenders. A further threat to the generalisability
of the results arises from the inclusion of only four prac-
tices in this study, potentially leading to high sampling
variability, compounded by the uneven distribution of
EHR reviews across these practices. As a consequence,
in the estimates of concordance generated by this study,
more weight has been given to those practices that con-
tributed more EHR reviews. This uncertain generalisabil-
ity should be borne in mind when applying the
diagnostic algorithms for other populations within the
MedicineInsight database.
Recording of the diagnosis in the original EHRs was
used as the reference standard against which the accur-
acy of the algorithms was benchmarked. The limitation
of this approach is that the recording of diagnoses in the
original EHR may be inaccurate or incomplete [19]. This
is a particular challenge in the Australian context, where
patients are able to obtain care at multiple general prac-
tices and information is not routinely shared between
practices. The extent to which diagnoses are not re-
corded completely may differ according to the specific
condition, with fragmentation of mental health care and
patient concerns about confidentiality contributing to
the under-recording of mental health conditions in pri-
mary health care EHRs [21]. Despite this, there is con-
sensus among experts that EHR reviews are an
acceptable reference standard for validation studies, with
the majority of validation studies of electronic primary
health care and other administrative health data using
EHR reviews as the reference standard [11, 16]. As an al-
ternative to EHR reviews, some prior validation studies
have asked general practitioners to complete question-
naires regarding the health of their individual patients.
However, this approach generally results in a low re-
sponse rate and limits the number of patients for whom
data can be collected [22]. Other validation studies have
used records in population-based data collections such
as cancer registries, hospital admissions data and death
registries as the reference standard [23, 24], but this is
not possible for MedicineInsight data until full-scale rec-
ord linkage is enabled.
Conclusions
Primary health care EHR databases are powerful re-
sources for improving our understanding of health and
healthcare practices. These databases typically provide
clinical information that is richer than that available
through administrative data or population surveys [1].
However, the extent to which the findings of analyses of
such data are a true reflection of patient health, and are
trusted by clinicians, policymakers and researchers, de-
pends on the accuracy of the data. This study measured
the accuracy of MedicineInsight algorithms for five
chronic conditions, finding that the algorithms for
asthma and osteoporosis have excellent accuracy and the
algorithms for anxiety, depression and type 2 diabetes
have good accuracy when compared to recording of
diagnoses in the original EHR. This study provides sup-
port for the use of these algorithms in the MedicineIn-
sight data for primary health care quality improvement
activities, research and health system policymaking and
planning.
General practices provided informed written consent
to participate in this research, and a waiver of the re-
quirement for individual patient consent was granted by
the NREEC.
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